Similar articles

• The promise of colony-stimulating factors in clinical practice.

  Glaspy JA, Ambersley JM. Glaspy JA, et al. Oncol Nurs Forum. 1990 Jan-Feb;17(1 Suppl):20-4. Oncol Nurs Forum. 1990. PMID: 1689043
• Therapeutic administration of recombinant human granulocyte colony-stimulating factor accelerates hemopoietic regeneration and enhances survival in a murine model of radiation-induced myelosuppression.

  Patchen ML, MacVittie TJ, Solberg BD, Souza LM. Patchen ML, et al. Int J Cell Cloning. 1990 Mar;8(2):107-22. doi: 10.1002/stem.5530080204. Int J Cell Cloning. 1990. PMID: 1690250
• Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosis.

  Champlin RE, Nimer SD, Oette D, Golde DW. Champlin RE, et al. Prog Clin Biol Res. 1990;338:143-50. Prog Clin Biol Res. 1990. PMID: 2189137 No abstract available.
• [GM-CSF: its use in onco-hematologic diseases].

  Visani G, Tosi P, Benfenati D, Colombini R, Cenacchi AR, Gamberi B, Lemoli RM, Tura S. Visani G, et al. Haematologica. 1989 Oct;74(5 Suppl):501-10. Haematologica. 1989. PMID: 2512232 Review. Italian. No abstract available.
• Granulocyte colony-stimulating factor: preclinical and clinical studies.

  Gabrilove JL, Jakubowski A. Gabrilove JL, et al. Hematol Oncol Clin North Am. 1989 Sep;3(3):427-40. Hematol Oncol Clin North Am. 1989. PMID: 2483722 Review.